Clinical features and treatment outcomes of vitiligo from the patients' perspective: Results of a national survey in germany

Dermatology

Volumn 220, Issue 3, 2010, Pages 194-200

  Radtke, Marc A ^a   Schäfer, Ines ^a   Gajur, Angelika I ^a   Augustin, Matthias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Patient benefit index; Patient satisfaction; Quality of life; Vitiligo

Indexed keywords

BETA CAROTENE; COLECALCIFEROL; CORTICOSTEROID; CORTISONE; COSMETIC; DERMATOLOGICAL AGENT; KHELLIN; PHENYLALANINE; PIMECROLIMUS; PSEUDOCATALASE; TACROLIMUS; UNCLASSIFIED DRUG; VITIX;

ADULT; ARTICLE; BODY SURFACE; CLINICAL FEATURE; COMORBIDITY; DISEASE DURATION; EXCIMER LASER; FEMALE; GERMANY; HEALTH SURVEY; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT SATISFACTION; PRIORITY JOURNAL; PUVA; QUESTIONNAIRE; SKIN TRANSPLANTATION; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADULT; FEMALE; GERMANY; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; TREATMENT OUTCOME; VITILIGO;

EID: 77951802433     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000275657     Document Type: Article

References (29)

1. Hahn SK, Nordlund JJ: Vitiligo. Oxford, Blackwell Sciences, 2000, pp 1-306.
2. Masini C, Abeni D: Vitiligo; in Williams H, Birgby M, Diepgen T, Herxheimer A, Naldi L, Rzany B (eds): Evidence-Based Dermatology, ed 4. London, BMJ Publishing Group, 2003.
3. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U: Interventions for vitiligo. Cochrane Database Syst Rev 2006; 1:CD003263.
4. Spritz RA: The genetics of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 244-257.
5. Salzer BA, Schallreuter KU: Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology 1995; 190: 109-115.
6. Le Poole IC, Luiten RM: Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 227-243.
7. Schallreuter KU, Bahadoran P, Picardo M, et al: Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008; 17: 139-140.
8. Namazi MR: Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? Pigment Cell Res 2007; 20: 360-363.
9. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y: Disorders of pigmentation; in Fitzpatrick T, Eisen A, Wolff K, Freedberg I, Austen K (eds): Fitzpatrick's Dermatology in General Medicine, ed 4. New York, McGraw-Hill, 1993.
10. Picardi A, Abeni D: Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70: 118-136.
11. Sukan M, Maner F: The problems in sexual functions of vitiligo and chronic urticaria patients. J Sex Marital Ther 2007; 33: 55-64. (Pubitemid 44949972)
12. Porter JR, Beuf AH: Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav 1991; 32: 192-204.
13. Porter JR, Beuf AH, Lerner A, Nordlund J: Personal response of patients to vitiligo. The importance of the interaction. Arch Dermatol 1978; 114: 1384-1385.
14. Rumpf HJ, Löntz W, Uesseler S: A self-administered version of a brief measure of suffering: first aspects of validity. Psychother Psychosom 2004; 73: 53-56.
15. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM: Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005; 152: 1165-1172.
16. Schmid-Ott G, Künsebeck HW, Jecht E, Shimshoni R, Lazaroff T, Schallmayer S, Calliess IT, Malewski P, Lamprecht F, Götz A: Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol 2007; 21: 456-461.
17. Whitton ME, Ashcroft DM, González U: Therapeutic interventions for vitiligo. J Am Acad Dermatol 2008; 59: 713-717.
18. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri- Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K: Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051-1076.
19. Fenton JS, Bergstrom KG: Vitiligo: nonsurgical treatment options and the evidence behind their use. J Drugs Dermatol 2008; 7: 705-711.
20. Njoo MD, Westerhof W, Bos JD, Bossuyt PM: The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell' Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol 1999; 135: 1514-1521.
21. Rychlik R, Wertheimer A, Rusche H, Augustin M, Nelles S, Böcking W: Policy decision making and outcomes research in drug utilization. Z Gesundheitswiss/J Public Health 2005; 1: 1-14.
22. Zentner A, Velasco-Garrido M, Busse R: Methods for the comparative evaluation of pharmaceuticals. GMS Health Technol Assess 1. 2005. http://www.egms.de/en/journals/ hta/2005-1/hta000009.shtml (accessed May 29, 2007).
23. Augustin M, Gajur AI, Reich C, Rustenbach SJ, Schaefer I: Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatology 2008; 217: 101-106.
24. Stangier U, Ehlers A, Gieler U: Fragebogen zur Bewältigung von Hautkrankheiten (FBH). Handanweisung. Göttingen, Hogrefe, 1996.
25. Augustin M, Reich K, Reich C, Purwins S, Rustenbach SJ, Schaefer I, Radtke M: Quality of psoriasis care in Germany - Results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 8: 640-645.
26. Rumpf HJ, Löntz W, Uesseler S: A self-administered version of a brief measure of suffering: first aspects of validity. Psychother Psychosom 2004; 73: 53-56.
27. Fleischer AB Jr, Feldman SR, Dekle CL: The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial. J Dermatol 1999; 26: 210-215.
28. Cazzaniga S, Sassi F, Mercuri SR, Naldi L: Prediction of clinical response to excimer laser treatment in vitiligo by using neural network models. Dermatology 2009; 219: 133-137.
29. Renders JM, Simonart T: Role of artificial neural networks in dermatology. Dermatology 2009; 219: 102-104